Abstract |
Lack of the AP-1 member c-Fos protects photoreceptors against light-induced apoptosis, a model for retinal degeneration. In mice, light damage increases the activity of the transcription factor AP-1, while pharmacological suppression of AP-1 prevents apoptosis, suggesting the involvement of pro-apoptotic AP-1 target genes. Recently, however, it was shown that photoreceptors expressing Fra-1 in place of c-Fos (Fos (Fosl1/Fosl1) ) are apoptosis competent despite the lack of transactivation domains in Fra-1. Here, we show that morphological features of light-induced apoptosis were indistinguishable in Fos (Fosl1/Fosl1) and wild-type mice. Furthermore, light exposure comparably increased AP-1 activity in both genotypes. Opposite to wild-type mice, Fra-1, but not c-Fos, was detectable in AP-1 complexes of Fos (Fosl1/Fosl1) mice. Importantly, AP-1 responsiveness for glucocorticoid receptor-mediated inhibition was preserved in Fos (Fosl1/Fosl1) mice. Thus, Fra-1 takes over for c-Fos in pro- and anti-apoptotic signal transduction. As Fra-1 lacks transactivation domains, AP-1 may not induce, but rather suppress genes in retinal light damage.
|
Authors | Andreas Wenzel, Hans Peter Iseli, Alexander Fleischmann, Farhad Hafezi, Christian Grimm, Erwin F Wagner, Charlotte E Remé |
Journal | Journal of neurochemistry
(J Neurochem)
Vol. 80
Issue 6
Pg. 1089-94
(Mar 2002)
ISSN: 0022-3042 [Print] England |
PMID | 11953459
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Glucocorticoids
- Proto-Oncogene Proteins c-fos
- Receptors, Glucocorticoid
- Transcription Factor AP-1
- fos-related antigen 1
- Dexamethasone
|
Topics |
- Animals
- Apoptosis
- Dexamethasone
(pharmacology)
- Disease Models, Animal
- Glucocorticoids
(pharmacology)
- In Situ Nick-End Labeling
- Light
(adverse effects)
- Mice
- Mice, Knockout
- Proto-Oncogene Proteins c-fos
(deficiency, genetics, metabolism)
- Receptors, Glucocorticoid
(metabolism)
- Retina
(drug effects, pathology, physiopathology, radiation effects)
- Retinal Degeneration
(pathology, physiopathology, prevention & control)
- Signal Transduction
- Transcription Factor AP-1
(metabolism)
- Transcriptional Activation
|